In lieu of federal action to either sure up the Affordable Care Act (ACA) or offer a viable alternative, states are now driving healthcare reform efforts aimed at addressing healthcare access and payment models for pharmaceuticals.
In lieu of federal action to either sure up the Affordable Care Act (ACA) or offer a viable alternative, states are now driving healthcare reform efforts aimed at addressing healthcare access and payment models for pharmaceuticals.